Dr. Kamila Anna Nowak Choi, MD ...

Dr. Kamila Nowak Choi

Claim this profile

MedStar Franklin Square Medical Center/Weinberg Cancer Institute

Studies Brain Tumor
Studies Brain Metastasis
7 reported clinical trials
19 drugs studied

Affiliated Hospitals

Image of trial facility.
MedStar Franklin Square Medical Center/Weinberg Cancer Institute
Image of trial facility.
UM Upper Chesapeake Medical Center

Clinical Trials Kamila Nowak Choi is currently running

Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria

More about Kamila Nowak Choi

Clinical Trial Related12 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Kamila Nowak Choi has experience with
  • Stereotactic Radiosurgery
  • Whole-Brain Radiotherapy
  • Cisplatin
  • Fractionated Stereotactic Radiosurgery
  • Single Fraction Stereotactic Radiosurgery
  • Memantine Hydrochloride

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Kamila Nowak Choi specialize in?
Is Kamila Nowak Choi currently recruiting for clinical trials?
Are there any treatments that Kamila Nowak Choi has studied deeply?
What is the best way to schedule an appointment with Kamila Nowak Choi?
What is the office address of Kamila Nowak Choi?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security